CRYDIS: – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Department of Pharmacy > Research > CRYDIS

CRYDIS:

Driving innovation in pharmaceuticals: integrated studies of physical dissolution properties of crystalline and amorphous forms using enhanced orthogonal monitoring techniques.

The aim of CRYDIS

CRYDIS undertakes innovative, collaborative research on the clinically-important topic of dissolution of drug substance particles in bio-relevant media and the undesired subsequent nucleation and re-precipitation of the drug prior to its absorption.

Using innovative advances in UV imaging technology, CRYDIS investigates the utility of novel dissolution assays as key tools to obtain fundamental data on the mechanism and kinetics of undesired nucleation and re-precipitation during or following dissolution, a significant problem for the pharmaceutical industry which struggles to obtain sufficient exposure to poorly soluble drug substances to ensure an effective dose is absorbed by the patient.

The key technologies in this project offer a step change in capability and functionality, offering the potential to undertake more detailed studies of the dissolution/re-precipitation processes relevant to pharmaceutical materials. Access to this key technology and the further development of its capability offers the potential for breakthroughs in development of process understanding and of robust and widely applicable protocols, thus, on a longer term perspective contributing to faster translation of molecules to medicines to patients.

About CRYDISTil toppen

CRYDIS is a Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) project under the European Union's Horizon 2020 programme running from January 2015 through December 2017.
The CRYDIS exchange programme will establish and support international and inter-sectoral transfer of knowledge and expertise in pharmaceutical and instrument science between several EU research institutes and industrial companies.

The project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 644056.

For further information please contact project coordinator Associate Professor Jesper Østergaard, Department of Pharmacy, University of Copenhagen, e-mail: jesper.ostergaard@sund.ku.dk.